Cardiome Pharma Corp. (Nasdaq: CRME) announced that it has launched XYDALBA in the UK earlier than expected. The European Medicines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE